Try our beta test site
9 studies found for:    Open Studies | "Rhinitis, Allergic, Seasonal"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Rhinitis, Allergic, Seasonal"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Effectiveness of Bifidobacteria in Children Affected by Seasonal Allergic Rhinitis
Condition: Seasonal Allergic Rhinitis
Interventions: Drug: Bifidobacteria;   Drug: placebo
2 Recruiting Efficacy and Safety Study of RAGWITEK™ (MK-3641) in Children With Ragweed-Induced Rhinoconjunctivitis With or Without Asthma (MK-3641-008)
Condition: Rhinitis, Allergic, Seasonal
Interventions: Biological: MK-3641;   Biological: Placebo;   Drug: Self-injectable epinephrine;   Drug: Albuterol/Salbutamol;   Drug: Loratadine;   Drug: Olopatadine;   Drug: Mometasone furoate monohydrate
3 Recruiting Clinical Efficacy and Safety of a Subcutaneous Immunotherapy With gpASIT+™ in Patients With Grass Pollen-induced Allergic Rhinoconjunctivitis
Condition: Hay Fever
Interventions: Biological: Placebo solution;   Biological: gpASIT+TM
4 Recruiting Evaluating Factors Involved in Dymista's Superior Clinical Efficacy to Fluticasone Propionate in the Treatment of Seasonal Allergic Rhinitis
Condition: Allergic Rhinitis
Interventions: Drug: Placebo;   Drug: Fluticasone propionate;   Drug: Fluticasone/Azelastine nasal spray;   Procedure: Nasal Allergen Challenge
5 Recruiting Dose Finding for the Treatment of Rhinitis/Rhinoconjunctivitis Against Grass Pollen Allergy
Conditions: Rhinitis;   Rhinoconjunctivitis
Interventions: Biological: MG56 Mannosylated 60 subcutaneous;   Biological: MG56 Mannosylated 100 subcutaneous;   Biological: MG56 Mannosylated 300 subcutaneous;   Biological: MG56 Mannosylated 500 subcutaneous;   Biological: MG56 Mannosylated 60 sublingual;   Biological: MG56 Mannosylated 100 sublingual;   Biological: MG56 Mannosylated 300 sublingual;   Biological: MG56 Mannosylated 500 sublingual;   Biological: Subcutaneous placebo;   Biological: Sublingual placebo
6 Not yet recruiting A Multicenter Study to Evaluate Safety and Efficacy of Specific Immunotherapy With Modified Allergen Extracts
Conditions: Allergic Rhinitis;   Allergic Conjunctivitis
Interventions: Biological: modified allergen extract;   Biological: Placebo
7 Not yet recruiting Efficacy and Safety of Sublingual Immunotherapy (SLIT)
Condition: Allergic Rhinitis
Interventions: Biological: sublingual immunotherapy with allergen extract;   Biological: sublingual immunotherapy with placebo
8 Not yet recruiting Developing Optimal Parameters for Hyperpolarized Noble Gas and Inert Fluorinated Gas MRI of Lung Disorders
Conditions: Lung Transplant;   Lung Resection;   Lung Cancer;   Asthma;   Cystic Fibrosis;   Chronic Obstructive Pulmonary Disease;   Emphysema;   Mesothelioma;   Asbestosis;   Pulmonary Embolism;   Interstitial Lung Disease;   Pulmonary Fibrosis;   Bronchiectasis;   Seasonal Allergies;   Cold Virus;   Lung Infection;   Pulmonary Hypertension;   Pulmonary Dysplasia;   Obstructive Sleep Apnea
Interventions: Drug: HP 3He;   Drug: HP 129Xe;   Drug: PFP;   Drug: SF6;   Device: 129Xe Small and Large Human Lung Coil;   Device: 3He Human Lung Coil;   Device: PFP and SF6 Human Lung Coil
9 Recruiting Development of Human Nasal Challenge Models With Microbial Constituents and Grass Pollen
Conditions: Allergic Rhinitis;   Asthma;   Latent Tuberculosis
Interventions: Other: TLR Agonist;   Other: Tuberculin nasal challenge;   Other: Timothy Grass Pollen

Study has passed its completion date and status has not been verified in more than two years.